Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

By G. Pagano, G. Pacini, G. Musso, R. Gambino, F. Mecca, N. Depetris, M. Cassader, E. David, P. Cavallo‐Perin, M. Rizzetto. Hepatology, 2002

787 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005, background): “Although the frequently sampled IVGTT has been employed to confirm the presence of insulin resistance in lean, non-diabetic patients with NAFLD [44], the impact of insulin resistance on lipid metabolism was not examined in this study.”
ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress? (2004, background): “Fatty liver changes have also been discussed as a possible mechanism to explain GGT – disease relationships([29,30]) even though fatty liver changes is recently regarded as one component of the insulin resistance syndrome by some researchers.([31,32]) However, the strong dose – response relationship”
Disordered lipid metabolism and the pathogenesis of insulin resistance. (2007, neutral): “Nonalcoholic steatohepatitis is also increasingly recognized as a component of the insulin resistance or metabolic syndrome (64, 76, 101).”
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). (2016, background): “[34] Pagano G, Pacini G, Musso G, et al.”
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study (2005, background): “0001 Ethanol (g/day) 1 (9)a 43 (36)b 11 (31)c ".”